205 related articles for article (PubMed ID: 31798355)
1. C-Reactive Protein to Albumin Ratio in Colorectal Cancer: A Meta-Analysis of Prognostic Value.
Zhou QP; Li XJ
Dose Response; 2019; 17(4):1559325819889814. PubMed ID: 31798355
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
Liao CK; Yu YL; Lin YC; Hsu YJ; Chern YJ; Chiang JM; You JF
World J Surg Oncol; 2021 May; 19(1):139. PubMed ID: 33933070
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.
Xie Q; Wang L; Zheng S
Dose Response; 2020; 18(2):1559325820931290. PubMed ID: 32647499
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of pretreatment albumin-globulin ratio in patients with colorectal cancer: A meta-analysis.
Ma JY; Liu G; Pan LZ; Hu M; Zhu ZZ
Medicine (Baltimore); 2022 May; 101(20):e29190. PubMed ID: 35608420
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
Yang X; Song X; Zhang L; Wu C
Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
[No Abstract] [Full Text] [Related]
9. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Li C; Zuo D; Liu T; Yin L; Li C; Wang L
Gastroenterol Res Pract; 2019; 2019():2391670. PubMed ID: 31933627
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis.
Wu J; Tan W; Chen L; Huang Z; Mai S
Oncotarget; 2018 Mar; 9(17):13934-13947. PubMed ID: 29568406
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.
Xu HJ; Ma Y; Deng F; Ju WB; Sun XY; Wang H
Onco Targets Ther; 2017; 10():3059-3070. PubMed ID: 28790840
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis.
Zhou W; Zhang GL
PLoS One; 2019; 14(10):e0224266. PubMed ID: 31644587
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of C-reactive protein to albumin ratio in metastatic colorectal cancer: A systematic review and meta-analysis.
Pan Y; Lou Y; Wang L
Medicine (Baltimore); 2021 Nov; 100(46):e27783. PubMed ID: 34797305
[TBL] [Abstract][Full Text] [Related]
18. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.
Yang Z; Zhang M; Peng R; Liu J; Wang F; Li Y; Zhao Q; Liu J
Int J Colorectal Dis; 2020 Sep; 35(9):1651-1661. PubMed ID: 32666290
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
Cui X; Jia Z; Chen D; Xu C; Yang P
Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
[TBL] [Abstract][Full Text] [Related]
20. Evaluating prognostic significance of preoperative C-reactive protein to albumin ratio in older patients with pathological stage II or III colorectal cancer.
Numata K; Ono Y; Ju M; Onuma S; Tanaka A; Kawabe T; Sawazaki S; Higuchi A; Yamanaka K; Hatori S; Saeki H; Matsukawa H; Rino Y; Tani K
Ann Coloproctol; 2024 Apr; 40(2):161-168. PubMed ID: 36217812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
